Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective

• 作者: Beatrice Aramini Khawaja Husnain Haider Valentina Masciale
• 来源期刊: 世界干细胞杂志:英文版(电子版)
• 学科: 医学
• 关键词: CANCER Cancer stem cells EXOSOMES Lungs miRNA MICROVESICLES Nonsmall cell lung cancer
• 年，卷（期）: 2020,（6）
• 页码范围: 406-421
• 页数: 16页
• 分类号: R73

摘要

Since the first publication regarding the existence of stem cells in cancer[cancer stem cells(CSCs)]in 1994,many studies have been published providing in-depth information about their biology and function.This research has paved the way in terms of appreciating the role of CSCs in tumour aggressiveness,progression,recurrence and resistance to cancer therapy.Targeting CSCs for cancer therapy has still not progressed to a sufficient degree,particularly in terms of exploring the mechanism of dynamic interconversion between CSCs and non-CSCs.Besides the CSC scenario,the problem of cancer dissemination has been analyzed indepth with the identification and isolation of microRNAs(miRs),which are now considered to be compelling molecular markers in the diagnosis and prognosis of tumours in general and specifically in patients with non-small cell lung cancer.Paracrine release of miRs via“exosomes”(small membrane vesicles(30-100 nm),the derivation of which lies in the luminal membranes of multi-vesicular bodies)released by fusion with the cell membrane is gaining popularity.Whether exosomes play a significant role in maintaining a dynamic equilibrium state between CSCs and non-CSCs and their mechanism of activity is as yet unknown.Future studies on CSC-related exosomes will provide new perspectives for precision-targeted treatment strategies.